Customize your JAMA Network experience by selecting one or more topics from the list below.
Hepatitis C virus (HCV) is a virus that can damage the liver.
About 2% of Americans are infected with HCV. Hepatitis C, the liver disease caused
by HCV, is a common worldwide problem and leads to 12,000 deaths each year in the United States. You can be
infected with the virus and not know you have it. Hepatitis C virus spreads by contact with blood from an infected individual.
A simple blood test can show if you are infected with HCV. Since 1992, all blood donations have been tested for HCV.
About three quarters of persons infected with HCV develop chronic (long-term) hepatitis.
Fortunately, only about one quarter develop progressive, irreversible liver damage. In those
cases, liver tissue is gradually destroyed over time and replaced with scar tissue (cirrhosis).
the presence of cirrhosis, liver failure and liver cancer can occur. The May 14, 2003, issue of JAMA includes an
article about hepatitis C.
Risk factors for hepatitis c infection
Blood transfusion or organ transplant before 1992
Exposure to infected blood
Illegal drug use (contaminated needles or other drug equipment)
Other types of hepatitis
(usually from food or feces contaminated by infected individuals)
(from infected blood, sexual contact, or mother-to-baby transmission)
Hepatitis D, E, and G
(usually from infected blood or blood products)
Treatments for hepatitis c infection
Alcohol use should be completely stopped because it greatly increases the risk for cirrhosis
Interferon (stops the virus from making more copies of itself)
Ribavirin (an antiviral medication)
Liver transplantation (if the patient 's liver is no longer functioning adequately)
Elimination of HCV from the body is possible, but the side effects of treatment can be serious.
Your doctor may suggest that mild cases of hepatitis C infection should be watched carefully
and treatment started if the disease begins to progress. Medical research studies are ongoing to
help answer questions about hepatitis C treatment. Transplantation of a new liver to replace the liver
damaged by hepatitis C is an option for treatment of advanced cirrhosis or early liver cancer. Transplantation is
limited by the number of organs available for donation. Liver transplantation is major surgery, and lifelong medications
are required after the transplant to prevent the body from rejecting the transplanted liver.
For more information
Hepatitis Foundation Internationalhttp://www.hepfi.org
American Liver Foundationhttp://www.liverfoundation.org
National Institute of Diabetes and Digestive and Kidney Diseaseshttp://www.niddk.nih.gov/health/digest/pubs/chrnhepc/chrnhepc.htm
To find this and previous JAMA Patient Pages, go to the Patient Page
link on JAMA 's Web site at http://www.jama.com. Many are available in
English and Spanish. A Patient Page on preventing hepatitis B was published in the November 10,1999,issue;and one
on diseases transmitted by blood and body fluids was published in the July 12, 2000,issue.
The JAMA Patient Page is a public service of JAMA. The
information and recommendations appearing on this page are appropriate in most instances, but they are not a
substitute for medical diagnosis. For specific information concerning your
personal medical condition, JAMA suggests that you consult your physician. This page may be
photocopied noncommercially by physicians and other health care professionals to share with patients.
Any other print or online reproduction is subject to
AMA approval. To purchase bulk reprints, call 718/946-7424.
Sources: National Institute of Diabetes and Digestive and Kidney Diseases,
National Institute of Allergy and Infectious Diseases
Topic: INFECTIOUS DISEASES
Torpy JM, Lynm C, Glass RM. Hepatitis C. JAMA. 2003;289(18):2450. doi:10.1001/jama.289.18.2350
Coronavirus Resource Center
Create a personal account or sign in to: